BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/13/2020 11:27:13 AM | Browse: 126 | Download: 100
Publication Name World Journal of Gastroenterology
Manuscript ID 51793
Country/Territory China
2019-10-18 14:38
Peer-Review Started
2019-10-18 14:39
To Make the First Decision
Return for Revision
2019-11-22 03:33
2019-12-06 11:46
Second Decision
2019-12-19 04:00
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2019-12-22 13:15
Articles in Press
2019-12-22 13:15
Publication Fee Transferred
Edit the Manuscript by Language Editor
2019-12-29 03:06
Typeset the Manuscript
2020-01-10 08:46
Publish the Manuscript Online
2020-01-13 11:27
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Observational Study
Article Title Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study
Manuscript Source Unsolicited Manuscript
All Author List Xin-Yue Lv, Hui-Guo Ding, Jun-Fu Zheng, Chun-Lei Fan and Lei Li
Author(s) ORCID Number
Xin-Yue Lv http://orcid.org/0000-0003-3553-9412
Hui-Guo Ding http://orcid.org/0000-0002-8716-4926
Jun-Fu Zheng http://orcid.org/0000-0003-3881-4088
Chun-Lei Fan http://orcid.org/0000-0001-7573-6045
Lei Li http://orcid.org/0000-0002-0295-9480
Funding Agency and Grant Number
Funding Agency Grant Number
the State Key Projects Specialized on Infectious Diseases 2017ZX10203202-004, 2017ZX10203202003008
Beijing Natural Science Foundation-Beijing Municipal Committee of Education KZ201810025037
Beijing high-level health technicians 2013-03-073
Beijing Municipal Administration of Hospitals' Ascent Plan DFL20151602
The Digestive Medical Coordinated Development Centre of the Beijing Municipal Administration of Hospitals XXZ0303
Corresponding author Lei Li, MD, PhD, Associate Professor, Chief Physician, Department of Gastroenterology and Hepatology, Beijing You An Hospital, Capital Medical University, 8 Xi TouTiao, Youanmenwai, Fengtai District,, Beijing 100069, China. m13699119545@163.com
Keywords Rifaximin; Cirrhosis; Refractory ascites; Inflammatory factors; Gut microbiota; Metagenomics sequencing
Core Tip This study showed that the unabsorbed antibiotics, rifaximin, mitigates ascites and improves the survival of cirrhotic patients with refractory ascites and the possible mechanism is that rifaximin regulates the structure and function of intestinal bacteria, thus improving the systemic inflammatory state.
Publish Date 2020-01-13 11:27
Citation Lv XY, Ding HG, Zheng JF, Fan CL, Li L. Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study. World J Gastroenterol 2020; 26(2): 199-218
Url https://www.wjgnet.com/1007-9327/full/v26/i2/199.htm
DOI https://dx.doi.org/10.3748/wjg.v26.i2.199
Full Article (PDF) WJG-26-199.pdf
Full Article (Word) WJG-26-199.docx
Manuscript File 51793-Review-Wang TQ.docx
Answering Reviewers 51793-Answering reviewers.pdf
Audio Core Tip 51793-Audio core tip.m4a
Biostatistics Review Certificate 51793-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 51793-Conflict-of-interest statement.pdf
Copyright License Agreement 51793-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 51793-Grant application form(s).pdf
Signed Informed Consent Form(s) or Document(s) 51793-Informed consent statement.pdf
Institutional Review Board Approval Form or Document 51793-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate 51793-Language certificate.pdf
Peer-review Report 51793-Peer-review(s).pdf
Scientific Editor Work List 51793-Scientific editor work list.pdf